Rx (Prescription Medicine)
USD $ 85.00
Pazeqol 200毫克片剂是一种处方药，通过抑制肿瘤生长，用于治疗晚期肾癌和软组织肉瘤。请遵医嘱服用，并告知医生您的任何健康状况或其他药物。
Pazeqol 200毫克片剂是一种处方药，含有活性成分帕唑帕尼。它主要用于治疗晚期肾细胞癌（肾癌）和晚期软组织肉瘤。帕唑帕尼通过抑制参与肿瘤生长和滋养肿瘤的新血管形成的一些酶（酪氨酸激酶）发挥作用。这种作用有助于减缓或阻止癌症的进展。
该剂型为片剂，通常口服。严格遵循医生开具的剂量和时间表至关重要。请勿压碎或咀嚼片剂。在开始服用Pazeqol之前，请告知您的医疗保健提供者任何既往病史，特别是肝脏问题、心脏病、高血压或甲状腺问题。同时，务必告知您正在服用的所有其他药物，包括非处方药和草药补充剂，以避免潜在的药物相互作用。将Pazeqol 200毫克片剂储存在室温下，远离潮湿和高温，并放在儿童接触不到的地方。
| Medicine Form | |
|---|---|
| Rx Status | |
| Medicine Type | |
| Molecule | |
| Brand Name | |
| Strength |
其他品牌的 Pazopanib 200 Mg — 同一活性成分且强度相同，但来自不同制造商。
医学审核
Renu Meena, B.Pharm
Medical Content Writer
Renu Meena is an experienced Medical Content Writer with a strong foundation in pharmacy practice. She holds a Bachelor of Pharmacy (B.Pharm) degree from Rajasthan University of Health Sciences (RUHS), Jaipur, and is registered with the Rajasthan State Pharmacy Council (Reg. No. 55661). With 4+ years of experience across clinical pharmacy and medical content development, she creates evidence-based content for medicines, diseases, and patient education. Her work is shaped by a strong understanding of pharmacovigilance and regulatory standards, including ICH guidelines, GVP modules, ICD-10/11, and safety reporting requirements. Renu focuses on making complex medical information simple, accurate, and useful for readers while maintaining high quality and compliance.
